cdx-301,ino-5151,bempegaldesleukin,ipilimumab,nivolumab
nektar therapeutics,inovio,bms,celldex
['porter', 'revolution']
with #sitc22 around the corner, look out for the nine pici-led studies featured this year, including the latest on #porter and #revolution trials with presentations from isabella glitza olivia, md, phd, and . details here: #picinetwork